Advancing Medical Science through Nanobiotechnology: Prospects, Applications, and Future Directions
Md Abu Bakar Siddique1*, Asim Debnath1, Nabil Deb Nath1, Md Abdur Rahman Biswash2, Tufael2
Journal of Primeasia 1.1(1) 1-7 https://doi.org/10.25163/primeasia.1110163
Submitted: 10 January 2018 Revised: 01 March 2018 Published: 02 March 2018
Abstract
Background: Nanobiotechnology brings together the fascinating world of nanotechnology and the field of biology, creating exciting possibilities for advancing medicine. This innovative area draws upon a wide range of knowledge and techniques from disciplines like engineering, physics, chemistry, and biology. Method: To understand how nanotechnology can enhance medical science, we conducted a thorough review of existing literature. This included examining its principles, the limitations it faces, the challenges researchers encounter, and the various applications it may have in healthcare. Results: Nanobiotechnology holds great promise for improving healthcare globally. Researchers are working on developing novel nanoparticles and nanodevices that could profoundly benefit human health. While we're not yet seeing widespread clinical applications of these technologies, many promising projects are making significant strides in the experimental stages. When nanotechnology is applied in medicine, it allows for highly precise interactions with the body's cellular and molecular structures. This level of specificity means that treatments can be more effective while minimizing side effects, and targeting specific cells or tissues in need. Conclusion: Despite the exciting potential of nanobiotechnology, there is still a lot of work to be done. We need more detailed research and thorough clinical trials to successfully integrate these innovations into everyday medical practice. Additionally, as we explore these new frontiers, it's crucial to address ethical and moral concerns related to the use of these technologies in healthcare.
Keywords: Nanobiotechnology, Applications, Medical, Molecular Diagnostics, Biomedical Innovation
References
Agrawal, A., Tripp, R. A., Anderson, L. J., & Nie, S. (2005). Real-time detection of virus particles and viral protein expression with two-color nanoparticle probes. Journal of Virology, 79(13), 8625–8628.
Allen, T. M., & Cullis, P. R. (2004). Drug delivery systems: Entering the mainstream. Science, 303(5665), 1818–1822.
Arangoa, M. A., Campanero, M. A., Renedo, M. J., Ponchel, G., & Irache, J. M. (2001). Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs: Relationships between bioadhesion and pharmacokinetics. Pharmaceutical Research, 18(10), 1521–1527.
Arbos, P., Campanero, M. A., Arangoa, M. A., & Irache, J. M. (2004). Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidines. Journal of Controlled Release, 96(1), 55–65.
Bao, Y. P., Wei, T. F., Lefebvre, P. A., An, H., He, L., & Kunkel, G. T., et al. (2006). Detection of protein analytes via nanoparticle-based bio bar code technology. Analytical Chemistry, 78(7), 2055–2059.
Bentolila, L. A., & Weiss, S. (2006). Single-step multicolor fluorescence in situ hybridization using semiconductor quantum dot-DNA conjugates. Cell Biochemistry and Biophysics, 45(1), 59–70.
Bentzen, E. L., House, F., Utley, T. J., Crowe, J. E., & Wright, D. W. (2005). Progression of respiratory syncytial virus infection monitored by fluorescent quantum dot probes. Nano Letters, 5(4), 591–595.
Buzea, C., Pacheco, I., & Robbie, K. (2007). Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases, 2(4), MR17.
Chan, P., Yuen, T., Ruf, F., Gonzalez-Maeso, J., & Sealfon, S. C. (2005). Method for multiplex cellular detection of mRNAs using quantum dot fluorescent in situ hybridization. Nucleic Acids Research, 33(18), e161.
Chen, Z., Meng, H., Xing, G., Chen, C., Zhao, Y., Jia, G., et al. (2006). Acute toxicological effects of copper nanoparticles in vivo. Toxicology Letters, 163(2), 109–120.
De Kozak, Y., Andrieux, K., Villarroya, H., Klein, C., Thillaye-Goldenberg, B., & Naud, M. C. (2004). Intraocular injection of tamoxifen-loaded nanoparticles: A new treatment of experimental autoimmune uveoretinitis. European Journal of Immunology, 34(12), 3702–3712.
Diwan, M., Elamanchili, P., Lane, H., Gainer, A., & Samuel, J. (2003). Biodegradable nanoparticle-mediated antigen delivery to human cord blood-derived dendritic cells for induction of primary T cell responses. Journal of Drug Targeting, 11(8-10), 495–507.
Elan Corporation, PLC. (2004). Available at http://www.elan.com/DrugDelivery
Elder, A., Gelein, R., Silva, V., Feikert, T., Opanashuk, L., Carter, J., et al. (2006). Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environmental Health Perspectives, 114(8), 1172–1178.
El-Shabouri, M. H. (2002). Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. International Journal of Pharmaceutics, 249(1-2), 101–118.
Emerich, D. F., & Thanos, C. G. (2003). Nanotechnology and medicine. Expert Opinion on Biological Therapy, 3(4), 655–663.
Ewert, K., Evans, H. M., Ahmad, A., Slack, N. L., Lin, A. J., Martin-Herranz, A., et al. (2005). Lipoplex structures and their distinct cellular pathways. Advances in Genetics, 53, 119–155.
Fan, R., Karnik, R., Yue, M., Li, D., Majumdar, A., & Yang, P. (2005). DNA translocation in inorganic nanotubes. Nano Letters, 5(9), 1633–1637.
Feng, S. S., Mu, L., & Win, K. Y. (2004). Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Current Medicinal Chemistry, 11(4), 413–424.
Garcia-Garcia, E., Gil, S., Andrieux, K., Desmaële, D., Nicolas, V., Taran, F., Georgin, D., Andreux, J. P., Roux, F., & Couvreur, P. (2005). A relevant in vitro rat model for the evaluation of blood–brain barrier translocation of nanoparticles. Cellular and Molecular Life Sciences, 62(12), 1400–1408.
Geho, D. H., Jones, C. D., Petricoin, E. F., & Liotta, L. A. (2006). Nanoparticles: Potential biomarker harvesters. Current Opinion in Chemical Biology, 10(1), 56–61.
Gourley, P. L., Hendricks, J. K., McDonald, A. E., Copeland, R. G., Barrett, K. E., & Gourley, C. R., et al. (2005). Mitochondrial correlation microscopy and nanolaser spectroscopy: New tools for biphotonic detection of cancer in single cells. Technology in Cancer Research & Treatment, 4(6), 585–592.
Guccione, S., Li, K. C., & Bednarski, M. D. (2004). Vascular-targeted nanoparticles for molecular imaging and therapy. Methods in Enzymology, 386, 219–236.
Hamad-Schifferli, K., Schwartz, J., Santos, A. T., Zhang, S., & Jacobson, J. (2002). Remote electronic control of DNA hybridization through inductive coupling to an attached metal nanocrystal antenna. Nature, 415(6869), 152–155.
Hart, S. L. (2005). Lipid carriers for gene therapy. Current Drug Delivery, 2(4), 423–428.
Hu, L., Tang, X., & Cui, F. (2004). Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. Journal of Pharmacy and Pharmacology, 56(12), 1527–1535.
Jain, K. K. (2003). Nanodiagnostics: Application of nanotechnology in molecular diagnostics. Expert Review of Molecular Diagnostics, 3(2), 153–161.
Jain, K. K. (2005). Nanotechnology in clinical laboratory diagnostics. Clinica Chimica Acta, 358(1-2), 37–54.
Jain, K. K. (2005). Nanotechnology-based lab-on-a-chip devices. In Fuchs, J. & Podda, M. (Eds.), Encyclopedia of Diagnostic Genomics and Proteomics (pp. 891–895). New York: Marcel Dekker Inc.
Jain, K. K. (2006). Nanobiotechnology in molecular diagnostics. Norwich, United Kingdom: Horizon Scientific Press.
Jain, K. K. (2007). Nanobiotechnology: Applications, markets and companies. Basel: Jain PharmaBiotech Publications.
Koping-Hoggard, M., Sanchez, A., & Alonso, M. J. (2005). Nanoparticles as carriers for nasal vaccine delivery. Expert Review of Vaccines, 4(2), 185–196.
Lam, C. W., James, J. T., McCluskey, R., & Hunter, R. L. (2004). Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicological Sciences, 77(1), 126–134.
LaVan, D. A., Lynn, D. M., & Langer, R. (2002). Timeline: Moving smaller in drug discovery and delivery. Nature Reviews Drug Discovery, 1(1), 77–84.
Lee, K. B., Park, S. J., Mirkin, C., Smith, J., & Mrkisch, M. A. (2002). Protein nanoarrays generated by dip-pen nanolithography. Science, 295(5560), 1702–1705.
Li, Z., Hulderman, T., Salmen, R., Chapman, R., Leonard, S. S., Young, S. H., et al. (2007). Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes. Environmental Health Perspectives, 115(3), 377–382.
Lin, H., & Datar, R. H. (2006). Medical applications of nanotechnology. National Medical Journal of India, 19(1), 27–32.
Lutsiak, M. E., Robinson, D. R., Coester, C., Kwon, G. S., & Samuel, J. (2002). Analysis of poly(d,l-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro. Pharmaceutical Research, 19(10), 1480–1487.
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000). Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. Journal of Controlled Release, 65(1-2), 271–284.
Maeda, M., Kuroda, C. S., Shimura, T., Tada, M., Abe, M., & Yamamuro, S., et al. (2006). Magnetic carriers of iron nanoparticles coated with a functional polymer for high throughput bioscreening. Journal of Applied Physics, 99(8), 08H103.
Medina, C., Santos-Martinez, M. J., Radomski, A., Corrigan, O. I., & Radomski, M. W. (2007). Nanoparticles: Pharmacological and toxicological significance. British Journal of Pharmacology, 150(5), 552–558.
Milunovich, S., & Roy, J. (2001). The next small thing: An introduction to nanotechnology. Merrill Lynch Report, September 4.
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005). Nanomedicine: Current status and future prospects. FASEB Journal, 19(3), 311–330.
NBTC (Nano-biotechnology Center, Cornell University). (2004). Home page. http://www.nbtc.cornell.edu/default.htm
Nijhara, R., & Balakrishnan, K. (2006). Bringing nanomedicines to market: Regulatory challenges, opportunities, and uncertainties. Nanomedicine, 2(2), 127–136.
Oberdörster, E. (2004). Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environmental Health Perspectives, 112(10), 1058–1062.
Panyam, J., & Labhasetwar, V. (2003). Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Advanced Drug Delivery Reviews, 55(3), 329–347.
Partlow, K. C., Chen, J., Brant, J. A., Neubauer, A. M., Meyerrose, T. E., & Creer, M. H., et al. (2007). 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. The FASEB Journal, 21(8), 1647–1654.
Price, R. L., Waid, M. C., Haberstroh, K. M., & Webster, T. J. (2003). Selective bone cell adhesion on formulations containing carbon nanofibers. Biomaterials, 24(11), 1877–1887.
Radomski, A., Jurasz, P., Onso-Escolano, D., Drews, M., Morandi, M., Malinski, T., et al. (2005). Nanoparticle-induced platelet aggregation and vascular thrombosis. British Journal of Pharmacology, 146(6), 882–893.
Ramachandran, N., Hainsworth, E., Bhullar, B., Eisenstein, S., Rosen, B., Lau, A. Y., et al. (2004). Self-assembling protein microarrays. Science, 305(5689), 86–90.
Robertson, J. W., Rodrigues, C. G., Stanford, V. M., Rubinson, K. A., Krasilnikov, O. V., & Kasianowicz, J. J. (2007). Single-molecule mass spectrometry in solution using a solitary nanopore. Proceedings of the National Academy of Sciences of the United States of America, 104(21), 8207–8211.
Sahoo, K. S., & Labhasetwar, V. (2003). Nanotech approaches to drug delivery and imaging. Drug Discovery Today, 8(24), 1112–1120.
Shaffer, C. (2005). Nanomedicine transforms drug delivery. Drug Discovery Today, 10(21), 1581–1582.
Ure, D., & Harris, J. (2003). Nanotechnology in dentistry: Reduction to practice. Dental Update, 30(1), 10–15.
Vasir, J. K., & Labhasetwar, V. (2005). Targeted drug delivery in cancer therapy. Technology in Cancer Research & Treatment, 4(4), 363–374.
Vasir, J. K., Reddy, M. K., & Labhasetwar, V. (2005). Nanosystems in drug targeting: Opportunities and challenges. Current Nanoscience, 1(1), 47–64.
Webster, T. J., Waid, M. C., McKenzie, J. L., Price, R. L., & Ejiofor, J. U. (2004). Nanobiotechnology: Carbon nanofibres as improved neural and orthopedic implants. Nanotechnology, 15(1), 48–54.
West, J. L., & Halas, N. J. (2000). Applications of nanotechnology to biotechnology commentary. Current Opinion in Biotechnology, 11(2), 215–217.
Wickline, S. A., Neubauer, A. M., Winter, P., Caruthers, S., & Lanza, G. (2006). Applications of nanotechnology to atherosclerosis, thrombosis, and vascular biology. Arteriosclerosis, Thrombosis, and Vascular Biology, 26(3), 435–441.
Williams, D. (2004). The risks of nanotechnology. Medical Device Technology, 15(5), 9–10.
Young, L. S., Searle, P. F., Onion, D., & Mautner, V. (2006). Viral gene therapy strategies: From basic science to clinical application. Journal of Pathology, 208(3), 299–318.
Zhang, Y., Schlachetzki, F., Li, J. Y., Boado, R. J., Pardridge, W. M., et al. (2003). Organ-specific gene expression in the rhesus monkey eye following intravenous nonviral gene transfer. Molecular Vision, 9, 465–472.
View Dimensions
View Altmetric
Save
Citation
View
Share